Takeda’s BLA for dengue vaccine candidate granted priority review by US FDA EP News Bureau Nov 23, 2022 TAK-003 is being evaluated for the prevention of dengue disease caused by any dengue virus serotype in individuals four years…
Gilead submits Biologics Licence Application to USFDA for Bulevirtide EP News Bureau Nov 23, 2021 If approved, Bulevirtide will be the first treatment option for adult patients in the US with chronic Hepatitis Delta Virus…
